Alyeska Investment Group
NERV icon

Alyeska Investment Group’s Minerva Neurosciences NERV Stock Holding History

Alyeska Investment Group’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,483
Closed -$692K – 481
2018
Q2 		$692K Buy
10,483
+335
+3% +$20.3K 0.01% 417
2018
Q1 		$507K Sell
10,148
-91
-0.9% -$4.37K ﹤0.01% 416
2017
Q4 		$496K Hold
10,239
– – ﹤0.01% 409
2017
Q3 		$623K Sell
10,239
-8,511
-45% -$488K ﹤0.01% 436
2017
Q2 		$1.33M Buy
+18,750
New +$1.21M 0.01% 381

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVAV
Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return

Alyeska Investment Group's NERV Position: Q3 2018 in Review

Alyeska Investment Group sold out of Minerva Neurosciences (NERV) in Q3 2018, closing a stake of 10,483 shares — an estimated $692K sold.

Alyeska Investment Group first reported a position in NERV in Q2 2017 and held it in 5 quarters. The position peaked at $1.33M in Q2 2017. 82 funds tracked by Wall St. Rank hold NERV as of Q3 2018.

  • Alyeska Investment Group reported no remaining Minerva Neurosciences position as of Q3 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 10,483 Minerva Neurosciences shares in Q3 2018, an estimated $692K.
  • Alyeska Investment Group first reported a position in Minerva Neurosciences in Q2 2017 and held it in 5 quarters.
  • Alyeska Investment Group's Minerva Neurosciences position peaked at $1.33M in Q2 2017.
  • 82 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2018.

Based on Alyeska Investment Group's 13F filing for Q3 2018, filed 14 Nov 2018.